Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia.

about

Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q40100584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Early infectious complications ...... py for acute myeloid leukemia.

@en

type

Item

label

Early infectious complications ...... py for acute myeloid leukemia.

@en

prefLabel

Early infectious complications ...... py for acute myeloid leukemia.

@en

P1476

Early infectious complications ...... apy for acute myeloid leukemia

@en

P2093

Amir T Fathi

http://www.w3.org/2001/XMLSchema#string

Andrew M Brunner

http://www.w3.org/2001/XMLSchema#string

Ashley M Perry

http://www.w3.org/2001/XMLSchema#string

Christelle P Joseph

http://www.w3.org/2001/XMLSchema#string

Gabriela S Hobbs

http://www.w3.org/2001/XMLSchema#string

Karen K Ballen

http://www.w3.org/2001/XMLSchema#string

Marla M Jalbut

http://www.w3.org/2001/XMLSchema#string

Philip C Amrein

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.

Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study.

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia.

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

P304

988-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1361028

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28792269

http://www.w3.org/2001/XMLSchema#string

P932

6197051

http://www.w3.org/2001/XMLSchema#string